Yentreve

duloxetine hydrochloride · Eli Lilly Nederland B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yentreve, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: EMA Authorised: Yentreve (duloxetine hydrochloride) — Eli Lilly Nederland B.V.